172 related articles for article (PubMed ID: 6162541)
1. Altered 5-azacytidine metabolism following 3-deazauridine treatment of L5178Y and human myeloblasts.
Grant S; Cadman E
Cancer Res; 1980 Nov; 40(11):4000-6. PubMed ID: 6162541
[TBL] [Abstract][Full Text] [Related]
2. Effect of uridine on response of 5-azacytidine-resistant human leukemic cells to inhibitors of de novo pyrimidine synthesis.
Grant S; Bhalla K; Gleyzer M
Cancer Res; 1984 Dec; 44(12 Pt 1):5505-10. PubMed ID: 6208998
[TBL] [Abstract][Full Text] [Related]
3. Metabolism and cytotoxicity of 5-azacytidine in cultured Novikoff rat hepatoma and P388 mouse leukemia cells and their enhancement by preincubation with pyrazofurin.
Plagemann PG; Behrens M; Abraham D
Cancer Res; 1978 Aug; 38(8):2458-66. PubMed ID: 78761
[TBL] [Abstract][Full Text] [Related]
4. Effect of N-(phosphonacetyl)-L-aspartate on 5-azacytidine metabolism in P388 and L1210 cells.
Grant S; Rauscher F; Jakubowski A; Cadman E
Cancer Res; 1981 Feb; 41(2):410-8. PubMed ID: 6160908
[TBL] [Abstract][Full Text] [Related]
5. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
Li ZR; Campbell J; Rustum YM
Cancer Treat Rep; 1983 Jun; 67(6):547-54. PubMed ID: 6190558
[TBL] [Abstract][Full Text] [Related]
6. The mechanism of action of 3-deazauridine in tumor cells sensitive and resistant to arabinosylcytosine.
Brockman RW; Shaddix SC; Williams M; Nelson JA; Rose LM; Schabel FM
Ann N Y Acad Sci; 1975 Aug; 255():501-21. PubMed ID: 171997
[TBL] [Abstract][Full Text] [Related]
7. Transport of uridine and 3-deazauridine in cultured human lymphoblastoid cells.
Dahlig-Harley E; Paterson AR; Robins MJ; Cass CE
Cancer Res; 1984 Jan; 44(1):161-5. PubMed ID: 6580947
[TBL] [Abstract][Full Text] [Related]
8. Prevention of methotrexate cytotoxicity by asparaginase inhibition of methotrexate polyglutamate formation.
Jolivet J; Cole DE; Holcenberg JS; Poplack DG
Cancer Res; 1985 Jan; 45(1):217-20. PubMed ID: 2578094
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic and biochemical effects of thymidine and 3-deazauridine on human tumor cells.
Lockshin A; Mendoza JT; Giovanella BC; Stehlin JS
Cancer Res; 1984 Jun; 44(6):2534-9. PubMed ID: 6722792
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity by 2,3-dihydro-1H-imidazolo[1,2-b]pyrazole in the human promyelocytic leukemic cell, HL-60.
Grant S; Bhalla K; Rauscher F; Cadman E
Cancer Res; 1983 Nov; 43(11):5093-100. PubMed ID: 6577943
[TBL] [Abstract][Full Text] [Related]
11. Synergistic action of 5-aza-2'-deoxycytidine and 3-deazauridine on L1210 leukemic cells and EMT6 tumor cells.
Momparler RL; Veselý J; Momparler LF; Rivard GE
Cancer Res; 1979 Oct; 39(10):3822-7. PubMed ID: 476619
[TBL] [Abstract][Full Text] [Related]
12. Effect of 5-azacytidine on differentiation and DNA methylation in human promyelocytic leukemia cells (HL-60).
Christman JK; Mendelsohn N; Herzog D; Schneiderman N
Cancer Res; 1983 Feb; 43(2):763-9. PubMed ID: 6184156
[TBL] [Abstract][Full Text] [Related]
13. 3-Deazauridine (NSC 126849): an interesting modulator of biochemical response.
Moriconi WJ; Slavik M; Taylor S
Invest New Drugs; 1986; 4(1):67-84. PubMed ID: 2422137
[TBL] [Abstract][Full Text] [Related]
14. Metabolism and effects of 5-(beta-D-ribofuranosyl)isocytosine in P815 cells.
Chou TC; Burchenal JH; Fox JJ; Watanabe KA; Chu CK; Philips FS
Cancer Res; 1979 Mar; 39(3):720-8. PubMed ID: 427759
[TBL] [Abstract][Full Text] [Related]
15. Comparative studies of the cytostatic action and metabolism of 5-azacytidine and 5,6-dihydro-5-azacytidine.
Voytek P; Beisler JA; Abbasi MM; Wolpert-DeFilippes MK
Cancer Res; 1977 Jul; 37(7 Pt 1):1956-61. PubMed ID: 67884
[TBL] [Abstract][Full Text] [Related]
16. Correlation of biochemical effects and incorporation of 3-deazaguanine into nucleic acids to cytotoxicity in L1210 cells.
Pieper RO; Barrows LR; Mandel HG
Cancer Res; 1986 Oct; 46(10):4960-5. PubMed ID: 3756857
[TBL] [Abstract][Full Text] [Related]
17. Dose- and schedule-dependent activation and drug synergism between thymidine and 5-aza-2'-deoxycytidine in a human promyelocytic leukemia cell line.
Grant S; Rauscher F; Margolin J; Cadman E
Cancer Res; 1982 Feb; 42(2):519-24. PubMed ID: 6173114
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of nucleoside transport in murine lymphoma L5178Y cells and human erythrocytes by the uridine phosphorylase inhibitors 5-benzylacyclouridine and 5-benzyloxybenzylacyclouridine.
Lee KH; el Kouni MH; Chu HS; Cha S
Cancer Res; 1984 Sep; 44(9):3744-8. PubMed ID: 6744292
[TBL] [Abstract][Full Text] [Related]
19. Effect of cordycepin on nucleic acid metabolism in L5178Y cells and on nucleic acid-synthesizing enzyme systems.
Müller WE; Seibert G; Beyer R; Breter HJ; Maidhof A; Zahn RK
Cancer Res; 1977 Oct; 37(10):3824-33. PubMed ID: 332340
[No Abstract] [Full Text] [Related]
20. Pyrazofurin metabolism, enzyme inhibition, and resistance in L5178Y cells.
Dix DE; Lehman CP; Jakubowski A; Moyer JD; Handschumacher RE
Cancer Res; 1979 Nov; 39(11):4485-90. PubMed ID: 498080
[No Abstract] [Full Text] [Related]
[Next] [New Search]
